This conference call transcript was computer generated and almost certianly contains errors. This transcript is provided for information purposes only.EarningsCall, LLC makes no representation about the accuracy of the aforementioned transcript, and you are cautioned not to place undue reliance on the information provided by the transcript.
11/3/2026
Hello everyone and welcome to AMWEL's conference call to discuss their third fiscal quarter of 2026. Joining us on the call today are AMWEL's Chairman and CEO, Dr. Ido Schoenberg and Mark Hirschhorn, AMWEL's CFO and Chief Operating Officer. Earlier today, a press release was distributed detailing their announcements. The earnings report is posted on the Amwell website at investors.amwell.com and is also available through normal news sources. This conference call is being webcast live on the IR page of the website where the replay will be archived. Before they begin prepared remarks, I'd like to take this opportunity to remind you that during the call, we will make forward-looking statements regarding projected operating results. and anticipated market opportunities. This forward-looking information is subject to the risks and uncertainties described in the filings with the SEC. Actual results or events may differ materially. Except as required by law, we undertake no obligation to update or revise these forward-looking statements. On this call, will refer to both the GAAP and non-GAAP financial measures. A reconciliation of GAAP and non-GAAP financial measures is provided in the earnings relief. With that, I would like to turn the call over to Ido.
Good evening and thank you for joining our third quarter earnings call. This was another quarter of steady progress. We set a goal at the start of the year, reach positive cash flow from operations and positive adjusted EBITDA in the fourth quarter and build from there. We beat our guidance for the quarter on both revenue and adjusted EBITDA. That makes nine quarters in a row of delivering our commitments to you. We are pleased with the quarter and with our progress across the business. And we have good visibility to that fourth quarter goal. Mark will take you through the numbers. Before he does, let me cover our market, our product, and recent developments in our company. Let me start with our customers because their reality shapes everything we do. Health plans and employers face their largest cost increases in about two decades. Costs are projected to rise another 8% to 11% in 2027. Last month, UnitedHealth said costs remain stubbornly high across the entire healthcare landscape. Premiums are not keeping pace. The easy fixes are gone. Technology-enabled care is one of the few levers left, but only if it comes with proof. That pressure is changing how health plans and employers buy. They no longer buy access. They buy engagement and outcomes. Most now tie digital health fees to performance. Nearly half of them say the programs they buy enroll fewer than one in four eligible members. Poor engagement is now the top reason they switch vendors. Health plans and employers face three major challenges in digital health today. The first is vendor sprawl. Dozens of point solutions, each with its own front door, costly to connect and hard to compare. The second is member confusion. A member who does not know where to start does not start. And the third is the lack of proof. It is hard to see which programs work and harder still to replace one Without disrupting members. That, Paul, is accelerating. AI has made it faster and cheaper to build a clinical program. Investors have backed hundreds of new digital health companies this year, many of them built on AI. Our customers feel pressure to offer these programs. But each one brings its own cost, its own integration, and its own front door. The opportunity is real. So is the complexity. More and more, a member's journey to care begins in a conversation with an AI assistant. Three in ten adults now use AI tools for health information at least once a month, up from about one in six two years ago. The question for our customers is where that conversation ends. It can end with a guess. It can end with care that is wrong for the member and wasteful for the plan. Or it can end with a covered in-network service that fits the member's need and has proven clinical and financial outcomes. This is the problem Amul is determined to solve for our customers. We help them improve clinical and financial outcomes. We do it through activation, getting more of their members into technology-enabled care in place of conventional care that often costs more. We give our customers one platform under their brand with one integration. It provides reliable, scalable rails to bring in a program, exchange data with it, and test whether it works. The members' experience A common data structure proves the outcomes and improves performance over time. As AI begins to transform healthcare, this platform becomes even more necessary. We are not selling an AI feature. We are the trusted platform where AI-powered care runs with clinicians in the loop. We extend our clients, we never compete with them That is why large and sophisticated organizations trust us with their members. Our customers together represent more than 90 million covered lives. We serve the 9.6 million beneficiaries of the military health system and the Department of Veteran Affairs has signaled its intent to do the same. Two recent recognitions point the same way. In September, Forst and Sullivan recognized AMWEL for technology innovation leadership. It cited our ability to address healthcare fragmentation through a unified platform. And Time Magazine named AMWEL to its list of the world's top health tech companies of 2026. Let me be specific about where we are focused for our customers today. There are six areas and all six run on the platform I just described. Three are about the member, getting members in, What they see and keeping them. Two are about the programs, our partners and our own. The last is the data that proves what works. For each I will describe the problem and what we do about it today. First activation. A customer gets value only when its members use the care it has bought. Most of the health plans we talk to still see engagement in the single digits. We address that with always-on engagement. Outreach to members through our customers' own channels within the rules they set. When a customer switches it fully on, members use the platform at more than three times the rate we see when it's off. Activation is where value begins. Without it, nothing else happens. With it, members get care, our customers get results, and we grow. Second, the member experience. We shipped a dramatically improved experience to most of our key customers. Returning members now see 3 screens instead of 12. Members rate their visits 4.9 out of 5. Behind that experience are the clinicians of the Amwell Medical Group. They provide urgent care, virtual primary care, and behavioral health, as well as nutrition and lactation programs. They are also empathetic guides through a confusing system. They help the member decide where to go next and they are a steady source of confidence. Thank you for your time today. So the relationship is durable and the member has a reason to come back. That matters to our customers because the clinician the member trusts is an effective referral point into the programs the customer has chosen. That is how activation compounds. Fourth choice. This is where the programs come in. The member should get the right program. Not just the available one. Our standard process brings a partner program live in weeks. One sign-on, one eligibility file, one data connection, one report, Under the customer's brand, our customers can add a program or replace one without disrupting members. That is choice without the sprawl. Fifth, behavioral health, where demand keeps rising and supply keeps falling short. SilverCloud is our behavioral health module on the Armwell platform. It automates the delivery of evidence-based care and it gives members a path to our own therapists and psychiatrists on the same platform. The evidence is building. Last month, we published a case study with Discovery Health, one of South Africa's largest health events. In its first 12 months, the program activated 22,000 members. 90% of surveyed users were satisfied. Among members with moderate to severe depression, 60 to 78% showed clinically significant improvement. And in the year after use, members' hospital costs related to mental health were 6% lower after adjusting for other factors. Activation first, with measured outcomes behind it. We prove, we do not claim. Sixth and last, data. A common data structure runs under everything I have described. It sends a member into a program with the right information. It collects outcomes back. And it reports value in the customer's own terms, whether that customer is a health plan or an employer that the plan serves. That is how a program proves its return on investment and how it gets better over time. Six areas, one platform. Together, they answer the three challenges I started with. Vendor sprawl, member confusion, and the lack of proof. That is where we are focused for our customers today and where we will keep investing. Let me turn to our government business, starting with the Department of Veterans Affairs. In September, we announced that the Department issued a letter of intent for us to deploy the Armoury Platform across its enterprise. The Department serves more than 9 million veterans. I want to be precise about what this is. The letter is not a binding contract. A definitive agreement still has to be negotiated and executed under federal procurement rules and that work is underway. The letter followed a comprehensive evaluation. It cited scalable video consultations, interoperability, cybersecurity compliance, and support for integrated care delivery. In plain terms, the capabilities the department evaluated are the ones we already run at scale for the military health system. And the department's own scale is considerable. In fiscal 2025, more than 2.9 million veterans use its telehealth services and it delivered more than 11.7 million video visits to the home. We are honored by that trust, and we are preparing for this work deliberately. With the Defense Health Agency, we continue to serve the military health system without interruption. We are negotiating the direct, longer-term contract that the Agency signaled its intent to award in June. Before I close, two principles guide how we run the company. The first is discipline. We are determined to keep improving efficiency and effectiveness across the business. We hold ourselves to the same standard we offer our customers. We measure results before we claim them. The second is focus. We are simplifying our efforts around a single differentiated To sum up, AI is multiplying the programs our customers can offer. Our platform is the reliable way to bring those programs to members and to prove which ones work. Virtual care for the military health system runs on it. The Department of Veteran Affairs has signaled its intent to follow. And we are doing all of this with discipline. We have good visibility to positive cash flow from operations and positive adjusted EBITDA in the fourth quarter. With that, I will turn the call over to Mark Horner. who will walk you through our operational and financial results. Mark.
Thanks, Ido, and good afternoon, everyone. On today's call, I'll start with the highlights from the third quarter, walk through our financial results in detail, and close with our outlook for the fourth quarter and the full year. In the third quarter, we delivered revenue above the high end of our guidance range and adjusted EBITDA toward the high end of our range. The outperformance was driven primarily by stronger-than-expected visit volumes and continued cost discipline. These results keep us on track toward our goal of generating positive cash flow from operations in the fourth quarter of this year. Total revenue for the third quarter was $49 million, down approximately 12.9% year-over-year, although $1 million above the high end of our guidance range. Subscription revenue was $23.9 million, down approximately 22.5% year-over-year and down approximately 6.8% sequentially. The year-over-year decline continues to reflect the previously disclosed churn we've discussed on prior earnings calls. AMWA Medical Group, or AMG, visit revenue was $23.7 million, up approximately 11.7% year-over-year and down approximately 3.1% sequentially, reflecting normal seasonality in visit volumes. AMG paid visits totaled approximately 301,000 visits, essentially flat year over year, with revenue per visit of approximately $79 per visit, up approximately $8 per visit, or 11%, from the third quarter of last year. That increase reflects favorable pricing and volume in urgent care along with the continued shift in our visit mix toward higher value clinical programs. Virtual primary care visits were up approximately 41% year over year continuing its strong growth trajectory. Total platform visits were approximately 760,000 visits down approximately 30.5% year over year which is consistent with the portfolio changes we've discussed previously. Gross profit was $26 million with a gross margin of 53% up approximately 57 basis points year over year from the 52.4% in the third quarter of 2025. The year over year improvement was driven by cost containment and higher clinical program revenue. As we've noted, our existing revenue mix is likely to produce a margin profile consistent with recent quarters, and we continue to expect our mix to shift toward higher margin SAS offerings over time. Total operating expenses, including depreciation and amortization, were $37.6 million, down approximately 36.1% year-over-year and up approximately 1.3% sequentially. As a percentage of revenue, operating expenses improved to 76.8% compared to 104.5% in the third quarter of last year and 71.3% last quarter. The year over year improvement reflects the benefit of our transformation actions, lower litigation costs, and continued cost discipline across the business. Adjusted EBITDA for the third quarter was a loss of $3.6 million compared to a loss of $12.7 million in the third quarter of 2025. That's a $9.1 million improvement. Operating loss was $11.7 million compared to a $29.3 million operating loss in the third quarter of 2025. and improvement of approximately 60%. Amwell's balance sheet continues to be very well positioned. We ended the quarter with approximately $181 million in cash and investments and zero debt. We expect to be in a very similar position at year end. Now turning to guidance. For the fourth quarter of 2026, we expect revenue in the range of 48 million to $50 million and adjusted EBITDA in the range of breakeven to a positive million dollars. This outlook reflects the typical seasonal pickup in visit volumes as we move into the winter months along with continued stability in our subscription base. For the full year, we are raising our guidance. We now expect full year 2026 revenue in the range of $204 million to $206 million compared to our prior range of $195 million to $205 million. We also now expect full year adjusted EBITDA to be a loss in the range of $6.9 million to $7.9 million, a meaningful improvement from our prior range of a loss of $12 million to $16 million. We continue to expect full year AMG visits at the high end of our previously communicated range of 1.32 million to 1.37 million visits. Our fourth quarter outlook reflects Thank you. Thank you. I'll turn it back to Ido.
You're reading a preview of the AMWL Q3 2026 earnings call.
Free account.
Want transcripts like this in your own app? Try the Earnings call API, or read the transcript API docs.
Use this data in your own app
Pull this call's transcript, audio and slides with the Earnings call transcripts API.
See pricing